Product NDC: | 55390-124 |
Proprietary Name: | Cladribine |
Non Proprietary Name: | Cladribine |
Active Ingredient(s): | 1 mg/mL & nbsp; Cladribine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-124 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075405 |
Marketing Category: | ANDA |
Start Marketing Date: | 20000228 |
Package NDC: | 55390-124-01 |
Package Description: | 1 VIAL in 1 BOX, UNIT-DOSE (55390-124-01) > 10 mL in 1 VIAL |
NDC Code | 55390-124-01 |
Proprietary Name | Cladribine |
Package Description | 1 VIAL in 1 BOX, UNIT-DOSE (55390-124-01) > 10 mL in 1 VIAL |
Product NDC | 55390-124 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cladribine |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20000228 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | CLADRIBINE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Purine Antimetabolite [EPC] |